Product Information
ZIDOVUDINE 300 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.4324 per EA under NDC 31722050960. Its NADAC has been published 536 times since Nov 28, 2013.
Strength
300 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722050960
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
2/18/2026
Active Ingredients
ZIDOVUDINEApproval Type
Generic (ANDA)
FDA Application
ANDA090092On Market Since
4/25/2008
Pharmacological Classes
Price Statistics
The NADAC for ZIDOVUDINE 300 MG TABLET has been published 536 times since Nov 28, 2013, and over the history we have for it it has risen 45.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4324 per EA |
|---|---|
| All-time high | $0.4991 (Dec 15, 2021) |
| All-time low | $0.2729 (Apr 23, 2014) |
| 52-week high | $0.4324 |
| 52-week low | $0.4016 |
| Median price | $0.4041 |
| Average price | $0.3955 |
| Largest weekly change | +41.0% (Dec 21, 2016) |
| Weeks tracked | 536 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 7% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ZIDOVUDINE 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ZIDOVUDINE 300 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $0.4324 per EA (NDC 31722050960), effective Jun 24, 2026.
How has the price of ZIDOVUDINE 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for ZIDOVUDINE 300 MG TABLET has risen 45.4%. It has been tracked across 536 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ZIDOVUDINE 300 MG TABLET?
Since Nov 28, 2013, the NADAC for ZIDOVUDINE 300 MG TABLET has ranged from a low of $0.2729 (Apr 23, 2014) to a high of $0.4991 (Dec 15, 2021), with a median of $0.4041 per EA.
Are there cheaper alternatives to ZIDOVUDINE 300 MG TABLET?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, ZIDOVUDINE 300 MG TABLET, is $0.4016 per EA — about 7% below ZIDOVUDINE 300 MG TABLET.
Who manufactures ZIDOVUDINE 300 MG TABLET?
ZIDOVUDINE 300 MG TABLET (NDC 31722050960) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification